Clinical Trials Directory

Trials / Completed

CompletedNCT04209426

Retrospective Observational Cohort Study of SYMBOL CUP DM 2

Etude de Cohorte Observationnelle Rétrospective SYMBOL CUP 2

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Dedienne Sante S.A.S. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a single-center retrospective observational cohort study of consecutively operated patients who underwent total hip arthroplasty (THA) with a SYMBOL CUP DMR HA or a SYMBOL CUP DM CEM hemispherical dual mobility acetabular implant. The purpose of this study is to estimate the safety and efficacy of those two implants at two-year follow-up.

Detailed description

Description according to PICOS (Patient, Intervention, Comparator, Outcomes, Study design) framework: Patients: \- Adult men and women requiring a total hip arthroplasty Intervention: \- THA with SYMBOL CUP DMR HA or SYMBOL CUP DM CEM hemispherical dual mobility acetabular implants. Comparator: None Outcomes: * Safety 1: Implant survival over 2-year follow-up. * Safety 2: All adverse events, with focus on implant dislocation, infections, revision surgery * Efficacy 1: Harris Hip Score (HHS) at baseline and 1-year follow-up. * Efficacy 2: Modified HHS (mHHS) consisting of pain + functional subscores at baseline, 1-year and 2-year follow-ups. * Efficacy 2: Devane score at baseline, 1-year and 2-year follow-ups. * Efficacy 3: Charnley classification at baseline, 1-year and 2-year followups. Study design: * single-center retrospective observational cohort study of consecutively operated patients who underwent total hip arthroplasty 2 years prior to study start. * Prospective 2-year follow-up letter and phone questionnaire.

Conditions

Interventions

TypeNameDescription
DEVICETHA with SYMBOL CUP DMR HA
DEVICETHA with SYMBOL CUP DM CEM

Timeline

Start date
2015-03-18
Primary completion
2018-03-31
Completion
2018-08-14
First posted
2019-12-24
Last updated
2025-04-18
Results posted
2025-04-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04209426. Inclusion in this directory is not an endorsement.